Ani Pharmaceuticals (ANIP) Goodwill (2013 - 2026)

Ani Pharmaceuticals has disclosed Goodwill across 14 years of filings, most recently posting $62.5 million for Q2 2026.

• In Q2 2026, Goodwill rose 3.22% year-over-year to $62.5 million; the TTM figure through Jun 2026 stood at $62.5 million (up 3.22% YoY), while the FY2025 annual figure was $62.5 million, up 4.15% from the prior year.
• Goodwill came in at $62.5 million for Q2 2026 at Ani Pharmaceuticals, roughly flat from $62.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $62.5 million in Q3 2025 to a low of $28.2 million in Q1 2022.
• Average Goodwill over 5 years is $43.0 million, with a median of $28.2 million recorded in 2022.
• Year-over-year, Goodwill soared 688.3% in 2022 and changed 0.0% in 2023.
• Over 5 years, Goodwill stood at $28.2 million in 2022, then changed by 0.0% to $28.2 million in 2023, then jumped by 112.57% to $60.0 million in 2024, then grew by 4.15% to $62.5 million in 2025, then changed by 0.0% to $62.5 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $62.5 million in Q2 2026, $62.5 million in Q1 2026, and $62.5 million in Q4 2025.